|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mao Y, Yang H, Xu H, Lu X, Sang X, Du S,
Zhao H, Chen W, Xu Y, Chi T, et al: Golgi protein 73 (GOLPH2) is a
valuable serum marker for hepatocellular carcinoma. Gut.
59:1687–1693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kladney RD, Bulla GA, Guo L, Mason AL,
Tollefson AE, Simon DJ, Koutoubi Z and Fimmel CJ: GP73, a novel
Golgi-localized protein uprcgulated by viral infection. Gene.
249:53–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang F, Gu Y, Li X, Wang W, He J and Peng
T: Upregulated Golgi phosphoprotein 2 (GOLPH2) expression in lung
adenocarcinoma tissue. Clin Biochem. 43:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagasue N, Galizia G, Kohno H, Chang YC,
Hayashi T, Yamanoi A, Nakamura T and Yukaya H: Adverse effects of
preoperative hepatic artery chemoembolization for resectable
hepatocellular carcinoma: A retrospective comparision of 138 liver
resection. Surgery. 106:81–86. 1989.PubMed/NCBI
|
|
6
|
Benowitz S: Liver cancer biomarkers
struggling to succeed. J Natl Cancer Inst. 99:590–591. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bruix J, Sherman M, Llovet JM, Beaugrand
M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M
and Rodés J: EASL Panel of Experts on HCC: Clinical management of
hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL
conference. European association for the study of the liver. J
Hepatol. 35:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Triantos C, Zisimopoulos K, Tsochatzis E,
Vlachogiannakos J, Manolakopoulos S, Rigamonti C, Goulis J, Manesis
E, Anastasiou J, Papalexi F, et al: 207 Meld vs cps for prognosis
in cirrhosis. Results from a multicentre study. J Hepatol.
52:(Suppl 1). S892010. View Article : Google Scholar
|
|
10
|
Bai H: Manual of tumor diagnosis and
treatment for primary physicians. Peking University Medical Press;
Beijing: pp. 3562008
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seldinger SI: Catheter replacement of the
needle in percutaneous arteriography; a new technique. Acta Radiol.
39:368–376. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saffroy R, Pham P, Reffas M, Takka M,
Lemoine A and Debuire B: New perspectives and strategy research
biomarkers for hepatocellular carcinoma. Clin Chem Lab Med.
45:1169–1179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Wan X, Li Z, Lin C, Zhan Y and Lu
X: Golgi protein 73 (GP73), a useful serum marker in liver
diseases. Clin Chem Lab Med. 49:1311–1316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oka H, Tamori A, Kuroki T, Kobayashi K and
Yamamoto S: Prospective study of alpha-fetoprotein in cirrhotic
patients monitored for development of hepatocellular carcinoma.
Hepatol. 19:61–66. 1994. View Article : Google Scholar
|
|
17
|
Pateron D, Ganne N, Trinchet JC,
Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P and
Beaugrand M: Prospective study of screening for hepatocellular
carcinoma in Caucasian patients with cirrhosis. J Hepatol.
20:65–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zoli M, Magalotti D, Bianchi G, Gueli C,
Marchesini G and Pisi E: Efficacy of a surveillance program for
early detection of hepatocellular carcinoma. Cancer. 78:977–985.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marrero JA, Romano PR, Nikolaeva O, Steel
L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS and Block
TM: GP73, a resident Golgi glycoprotein, is a novel serum marker
for hepatocellular carcinoma. J Hepatol. 43:1007–1012. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Norton PA, Comunale MA, Krakover J,
Rodemich L, Pirog N, D'Amelio A, Philip R, Mehta AS and Block TM:
N-linked glycosylation of the liver cancer biomarker GP73. J Cell
Biochem. 104:136–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riener MO, Stenner F, Liewen H, Soll C,
Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N,
Hellerbrand C, Müllhaupt B, et al: Golgi phosphoprotein 2 (GOLPH2)
expression in liver tumors and its value as a serummarker in
hepatocellular carcinomas. Hepatology. 49:1602–1609. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poon Tung-Ping R, Fan ST and Wong J: Risk
factors, prevention, and management of postoperative recurrence
after resection of hepatocellular carcinoma. Ann Surg. 232:10–24.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimada K, Sano T, Sakamoto Y and Kosuge
T: A long-term follow-up and management study of hepatocellular
carcinoma patients surviving for 10 years or longer after curative
hepatectomy. Cancer. 104:1939–1947. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu JS, Wu DW, Liang S and Miao XY: GP73, a
resident Golgi glycoprotein, is sensibility and specificity for
hepatocellular carcinoma of diagnosis in a hepatitis B-endemic
Asian population. Med Oncol. 27:339–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou Y, Yin X, Ying J and Zhang B: Golgi
protein 73 versus alpha-fetoprotein as a biomarker for
hepatocellular carcinoma: A diagnostic meta-analysis. BMC Cancer.
12:172012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iftikhar R, Kladney RD, Havlioglu N,
Schmitt-Gräff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR and
Fimmel CJ: Disease- and cell-specific expression of GP73 in human
liver disease. Am J Gastroenterol. 99:1087–1095. 2004. View Article : Google Scholar : PubMed/NCBI
|
